- Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
-
Guzel S, Serin O, Guzel EC, Buyuk B, Yilmaz G, Guvenen G
- KMID: 1776468
- Korean J Intern Med.
- 2013 May;28(3):386-386.
- doi: 10.3904/kjim.2013.28.3.386
In the article, there were two spelling errors in the title and author affiliation. -
- CITED
-
- Close
- SHARE
-
- Close
- Vascular Cell Adhesion Molecule 1, Intercellular Adhesion Molecule 1, and Cluster of Differentiation 146 Levels in Patients with Type 2 Diabetes with Complications
-
Hocaoglu-Emre FS, Saribal D, Yenmis G, Guvenen G
- KMID: 2413293
- Endocrinol Metab.
- 2017 Mar;32(1):99-105.
- doi: 10.3803/EnM.2017.32.1.99
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a multisystemic, chronic disease accompanied by microvascular complications involving various complicated mechanisms. Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1),... -
- CITED
-
- Close
- SHARE
-
- Close
- Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
-
Guzel S, Serin O, Guzel EC, Buyuk B, Yilmaz G, Guvenen G
- KMID: 1501771
- Korean J Intern Med.
- 2013 Mar;28(2):165-173.
- doi: 10.3904/kjim.2013.28.2.165
BACKGROUND/AIMS: Acute coronary syndrome (ACS) is characterized by increased inflammatory processes and endothelial activation. We investigated the association between ACS and inflammatory mediators and matrix-degrading enzymes. METHODS: We prospectively enrolled 55... -
- CITED
-
- Close
- SHARE
-
- Close
